EPA-0775 – Efficacy of lisdexamfetamine dimesylate and atomoxetine in child and adolescent subgroups from a head-tohead, double-blind, randomized trial in patients with attention-deficit/hyperactivity disorder

Autor: Dittmann, R.W., Cardo, E., Coghill, D.R., Nagy, P., Anderson, C.S., Adeyi, B., Caballero, B., Hodgkins, P., Civil, R.
Zdroj: In European Psychiatry 2014 29 Supplement 1:1-1
Databáze: ScienceDirect